Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study.

Authors:
Xu J; Wang G; Chen X; Shen Y; Wang X and 1 more

Journal:
Thromb J

Publication Year: 2023

DOI:
10.1186/s12959-023-00456-9

PMCID:
PMC9890768

PMID:
36726149

Journal Information

Full Title: Thromb J

Abbreviation: Thromb J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Peripheral Vascular Disease

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateAccording to the ethical guidelines of the Helsinki Declaration, the study protocol was approved by the Research and Ethics Board of Peking University Cancer Hospital & Institute. As this was an observational study, the requirement for informed consent was waived. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding Not applicable."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025